Wet Macular Degeneration

Showing 1 - 25 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Germany, Switzerland (Brolucizumab)

Recruiting
  • Age-related Macular Degeneration
  • +5 more
  • Brolucizumab
  • Regensburg, Bavaria, Germany
  • +32 more
Jan 20, 2023

Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

Completed
  • Wet Macular Degeneration
  • Phoenix, Arizona
  • +138 more
Dec 16, 2022

Artificial Intelligence Diagnostic Aid

Not yet recruiting
  • Wet Macular Degeneration
  • +2 more
  • Macusense Assessment Software
  • London, Westminster, United Kingdom
    Guy's and St Thomas's NHS Foundation Trust
Dec 29, 2022

Wet Macular Degeneration Trial in Germany, United Kingdom, United States (BI 836880)

Suspended
  • Wet Macular Degeneration
  • BI 836880
  • Palo Alto, California
  • +13 more
Aug 24, 2022

Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

Withdrawn
  • Wet Macular Degeneration
  • Aflibercept 40 MG/ML [Eylea]
  • +2 more
  • Prague, Czechia
    Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022

Wet Macular Degeneration Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Terminated
  • Wet Macular Degeneration
  • Phoenix, Arizona
  • +74 more
Jun 2, 2022

Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

Completed
  • Wet Macular Degeneration
  • Mesa, Arizona
  • +159 more
Apr 6, 2022

Retinal Revascularization and Clinical Indicators of Neovascular

Recruiting
  • Wet Macular Degeneration
  • Ophthalmic Drugs
  • Arendal, Agder, Norway
    Sorlandet Hospital HF
Mar 3, 2022

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

Completed
  • Age-related Macular Degeneration
  • +2 more
  • bevacizumab
  • ranibizumab
  • Tucson, Arizona
  • +49 more
Feb 15, 2022

Wet Macular Degeneration Trial in Los Angeles (Aflibercept Ophthalmic, optovue angiovue)

Completed
  • Wet Macular Degeneration
  • Aflibercept Ophthalmic
  • optovue angiovue
  • Los Angeles, California
    Stein Eye Institute of UCLA
Dec 9, 2021

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,

Active, not recruiting
  • Age-Related Macular Degeneration
  • +4 more
  • bevacizumab
  • Springfield, Illinois
  • +2 more
Dec 6, 2021

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

Completed
  • Age-related Macular Degeneration
  • +4 more
  • bevacizumab
  • Tucson, Arizona
  • +19 more
Nov 16, 2021

Neovascular Age-related Macular Degeneration, Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in United

Recruiting
  • Neovascular Age-related Macular Degeneration
  • +2 more
  • RGX-314
  • Phoenix, Arizona
  • +12 more
Oct 12, 2021

Connective Tissue Growth Factor in Neovascular Age Related

Recruiting
  • Wet Macular Degeneration
    • Baltimore, Maryland
      Wilmer Eye Institute at Johns Hopkins University
    Sep 3, 2021

    Reading Speed Improvements in Wet-AMD Patients After Ranibizumab

    Completed
    • Ophthalmopathy
    • Wet Macular Degeneration
      • (no location specified)
      Jul 20, 2021

      Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia

      Completed
      • Age-related Macular Degeneration
      • +2 more
      • bevacizumab
      • ranibizumab
      • Hurstville, New South Wales, Australia
      • +8 more
      May 7, 2021

      Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)

      Terminated
      • Choroidal Neovascularization
      • Wet Macular Degeneration
      • ICON-1
      • aflibercept
      • Beverly Hills, California
      • +7 more
      Mar 21, 2021

      Macular Degeneration, Wet Macular Degeneration Trial in La Jolla (Intravitreal aflibercept injection)

      Completed
      • Macular Degeneration
      • Wet Macular Degeneration
      • Intravitreal aflibercept injection
      • La Jolla, California
        Shiley Eye Center
      Mar 23, 2021

      Wet Macular Degeneration Trial in Portugal, Spain (Retilut, Theavit)

      Completed
      • Wet Macular Degeneration
      • Retilut
      • Theavit
      • Celas, Coimbra, Portugal
      • +8 more
      Feb 11, 2021

      Age-Related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Phoenix, Abilene, Arecibo

      Completed
      • Age-Related Macular Degeneration
      • +5 more
      • brolucuzumab 6 mg IVT
      • Phoenix, Arizona
      • +2 more
      Dec 9, 2020

      Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in Virginia Beach (Ziv-Aflibercept 25 MG/ML [Zaltrap],

      Completed
      • Wet Macular Degeneration
      • Wet Age-related Macular Degeneration
      • Virginia Beach, Virginia
        Wagner Macula & Retina Center
      Oct 5, 2020

      Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

      Completed
      • Neovascular Age-related Macular Degeneration
      • Wet Macular Degeneration
      • Palo Alto, California
      • +4 more
      Jun 5, 2020

      Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet

      Completed
      • Wet Macular Degeneration
      • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
      • Multiple Locations, France
        (unnamed)
      Apr 15, 2020

      Subfoveal Hemorrhage in Neovascular Age-Related Macular

      Terminated
      • Submacular Hemorrhage
      • +2 more
      • Baltimore, Maryland
        Wilmer Eye Institute, Johns Hopkins
      Feb 17, 2020